These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23165852)

  • 21. Tuberculous cervical lymphadenitis.
    Tomblin JL; Roberts FJ
    Can Med Assoc J; 1979 Aug; 121(3):324-30. PubMed ID: 111794
    [No Abstract]   [Full Text] [Related]  

  • 22. [Primary tuberculosis of the palatine tonsil].
    Chumakov FI; Luk'ianova MA
    Probl Tuberk; 1997; (3):60-1. PubMed ID: 9265182
    [No Abstract]   [Full Text] [Related]  

  • 23. Scrofula in a Child.
    Pereira C; Cascais M; Félix M; Salgado M
    J Pediatr; 2017 Oct; 189():235. PubMed ID: 28728809
    [No Abstract]   [Full Text] [Related]  

  • 24. Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up.
    Papp KA; Griffiths CE; Gordon K; Lebwohl M; Szapary PO; Wasfi Y; Chan D; Hsu MC; Ho V; Ghislain PD; Strober B; Reich K; ; ;
    Br J Dermatol; 2013 Apr; 168(4):844-54. PubMed ID: 23301632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ustekinumab (Stelara) for psoriasis.
    Med Lett Drugs Ther; 2010 Jan; 52(1330):7-8. PubMed ID: 20208473
    [No Abstract]   [Full Text] [Related]  

  • 26. An update on the long-term safety experience of ustekinumab: results from the psoriasis clinical development program with up to four years of follow-up.
    Reich K; Papp KA; Griffiths CE; Szapary PO; Yeilding N; Wasfi Y; Ott E; Hsu MC; Lebwohl M; Gordon KB;
    J Drugs Dermatol; 2012 Mar; 11(3):300-12. PubMed ID: 22395580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unusual presentation of tuberculosis in an infliximab-treated patient--which is the correct TB screening before starting a biologic?
    Gori A; Fabroni C; Prignano F; Lotti T
    Dermatol Ther; 2010; 23 Suppl 1():S1-3. PubMed ID: 20136915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psoriasiform type of lichen scrofulosorum: clue to disseminated tuberculosis.
    Kumar U; Sethuraman G; Verma P; Das P; Sharma VK
    Pediatr Dermatol; 2011; 28(5):532-4. PubMed ID: 21133997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transmission of Mycobacterium tuberculosis by accidental needlestick.
    Oymak SF; Gülmez I; Demir R; Ozesmi M
    Respiration; 2000; 67(6):696-7. PubMed ID: 11124657
    [No Abstract]   [Full Text] [Related]  

  • 30. No reactivation of tuberculosis in patients with latent tuberculosis infection receiving ixekizumab: A report from 16 clinical studies of patients with psoriasis or psoriatic arthritis.
    Mrowietz U; Riedl E; Winkler S; Xu W; Patel H; Agada N; Lebwohl MG
    J Am Acad Dermatol; 2020 Nov; 83(5):1436-1439. PubMed ID: 32526319
    [No Abstract]   [Full Text] [Related]  

  • 31. The evolving role of biologics in the treatment of pediatric psoriasis.
    Luu M; Cordoro KM
    Skin Therapy Lett; 2013 Feb; 18(2):1-4. PubMed ID: 23508772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Lymph node tuberculosis treatment: from recommendations to practice].
    Lanoix JP; Douadi Y; Borel A; Andrejak C; El Samad Y; Ducroix JP; Schmit JL
    Med Mal Infect; 2011 Feb; 41(2):87-91. PubMed ID: 21106315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Eosinophilia during psoriasis treatment with TNF antagonists.
    Malisiewicz B; Murer C; Pachlopnik Schmid J; French LE; Schmid-Grendelmeier P; Navarini AA
    Dermatology; 2011; 223(4):311-5. PubMed ID: 22301393
    [No Abstract]   [Full Text] [Related]  

  • 34. Anti-tumour necrosis factor-α treatment and weight gain in psoriasis: the 'pudgy blanching' conundrum.
    Puig L
    Br J Dermatol; 2013 May; 168(5):923-4. PubMed ID: 23614557
    [No Abstract]   [Full Text] [Related]  

  • 35. Incidence of serious gastrointestinal events among tildrakizumab-treated patients with psoriasis: Letter to the Editor.
    Gooderham M; Elewski BE; Pariser DM; Sofen H; Mendelsohn AM; Rozzo SJ; Li Q
    J Eur Acad Dermatol Venereol; 2019 Oct; 33(10):e350-e352. PubMed ID: 31033068
    [No Abstract]   [Full Text] [Related]  

  • 36. [Lymph node tuberculosis: epidemiology, diagnostic and therapeutic aspects, about 357 cases].
    Hamzaoui G; Amro L; Sajiai H; Serhane H; Moumen N; Ennezari A; Yazidi AA
    Pan Afr Med J; 2014; 19():157. PubMed ID: 25767675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paradoxical reaction during tuberculosis treatment in HIV-seronegative patients.
    Carvalho AC; De Iaco G; Saleri N; Pini A; Capone S; Manfrin M; Matteelli A
    Clin Infect Dis; 2006 Mar; 42(6):893-5. PubMed ID: 16477577
    [No Abstract]   [Full Text] [Related]  

  • 38. First emergence of pyoderma gangraenosum, palmoplantar pustulosis and sacroiliitis in a psoriasis patient associated with switching from secukinumab to brodalumab.
    Sadik CD; Thieme M; Zillikens D; Terheyden P
    J Eur Acad Dermatol Venereol; 2019 Nov; 33(11):e406-e407. PubMed ID: 31131924
    [No Abstract]   [Full Text] [Related]  

  • 39. The safety of ustekinumab treatment in patients with moderate-to-severe psoriasis and latent tuberculosis infection.
    Tsai TF; Ho V; Song M; Szapary P; Kato T; Wasfi Y; Li S; Shen YK; Leonardi C;
    Br J Dermatol; 2012 Nov; 167(5):1145-52. PubMed ID: 22803615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrated safety analysis of treatment-emergent eczematous reactions in patients with moderate-to-severe psoriasis treated with ixekizumab, etanercept and ustekinumab.
    Brunner PM; Conrad C; Vender R; Grond S; Schuster C; Patel H; Xu W; Carrascosa Carrillo JM
    Br J Dermatol; 2021 Oct; 185(4):865-867. PubMed ID: 34076896
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.